首页> 外国专利> BENZENESULFONYL(THIO)UREAS IN COMBINATION WITH BETA-BLOCKERS FOR THE TREATMENT OF DYSFUNCTIONS OF THE AUTONOMOUS NERVOUS SYSTEM

BENZENESULFONYL(THIO)UREAS IN COMBINATION WITH BETA-BLOCKERS FOR THE TREATMENT OF DYSFUNCTIONS OF THE AUTONOMOUS NERVOUS SYSTEM

机译:苯磺酰脲(硫)脲与β-受体阻滞剂合用治疗自主神经系统功能障碍

摘要

Substituted benzenesulfonylureas and -thioureas of the formula Iin which R1, R2, E, X, Y and Z have the meanings described herein, show effects on the autonomous nervous system. The invention relates to the use of the compounds of the formula I in the treatment and prophylaxis of dysfunctions of the autonomous nervous system, in particular of vagal dysfunctions, for example in the case of cardiovascular diseases. The invention also relates to the use of compounds of the formula I in combination with beta-receptor blockers and to products and pharmaceutical preparations which comprise at least one compound of the formula I and at least one beta-receptor blocker, and to novel compounds.
机译:其中R 1,R 2,E,X,Y和Z具有本文所述含义的式I的取代的苯磺酰脲和-硫脲显示对自主神经系统的作用。本发明涉及式I化合物在治疗和预防自主神经系统功能障碍,特别是迷走神经功能障碍,例如在心血管疾病中的用途。本发明还涉及式I化合物与β-受体阻滞剂组合的用途,并且涉及包含至少一种式I化合物和至少一种β-受体阻滞剂的产品和药物制剂,并且涉及新化合物。

著录项

  • 公开/公告号HU228988B1

    专利类型

  • 公开/公告日2013-07-29

    原文格式PDF

  • 申请/专利权人 SANOFI-AVENTIS DEUTSCHLAND GMBH;

    申请/专利号HU20010003534

  • 申请日1999-09-02

  • 分类号A61K31/64;C08K3/04;A61K31/138;A61K31/145;A61K31/165;A61K31/166;A61K31/17;A61K31/18;A61K31/382;A61K31/403;A61K31/404;A61K31/4412;A61K31/5377;A61P3/10;A61P9;A61P9/04;A61P9/10;A61P25;A61P25/02;A61P43;C07C311/58;C07C335/42;C08C2/06;C08J3/14;C08K3/06;C08K5/54;C08L21;

  • 国家 HU

  • 入库时间 2022-08-21 16:41:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号